Celon Pharma S.A. Celon Pharma S.A.

Celon Pharma S.A.

CLN

Rank in Stocks #16275
Celon Pharma S.A. operates as a fully-integrated pharmaceutical firm,... Celon Pharma S.A. operates as a fully-integrated pharmaceutical firm, undertaking the investigation, development, production, and distribution of diverse medicinal formulations. Its business model is structured around two principal areas: generic drug offerings and innovative therapeutic solutions. The company's product line addresses a range of health challenges, including oncological conditions, neurological disorders, diabetes, and other metabolic complaints. Established in 2002, this enterprise is situated in Lomianki, Poland, and functions as a subsidiary of Glatton Sp. z o.o.
Share Price
$4.02
Last synced: 2026-11-12
Market Cap
$216.94M
Change (1 day)
-3.51%
Change (1 year)
-32.26%
Country

Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this

Category

Healthcare
Operating Margin for Celon Pharma S.A. (CLN)
Operating Margin as of November 2026 TTM: -11.78%
According to Celon Pharma S.A.'s latest financial reports, its current operating margin (TTM) is -11.78%. At the end of 2025 the company had an operating margin of -27.06%.
Operating Margin history for Celon Pharma S.A. from 2012 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
2026 (TTM) -11.78% -56.47%
2025 -27.06% 29.85%
2024 -20.84% 63.71%
2023 -12.73% -70.45%
2022 -43.08% 708.26%
2021 -5.33% 128.76%
2020 -2.33% -134.52%
2019 6.75% -76.26%
2018 28.43% 17.19%
2017 24.26% -33.61%
2016 36.54% -16.75%
2015 43.89% 47.38%
2014 29.78% -2.87%
2013 30.66% 431.37%
2012 5.77% 0.00%
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
19.69% -101.67%
DE
19.68% -101.67%
DE
13.26% -101.13%
JP
17.08% -101.45%
CH
10.53% -100.89%
IL
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.

Questions about Celon Pharma S.A.'s operating margin

What is Celon Pharma S.A.'s operating margin?

Celon Pharma S.A.'s operating margin is -11.78%, as of Nov 2026.

What was Celon Pharma S.A.'s operating margin in 2025?

In 2025, Celon Pharma S.A.'s operating margin was -27.06%, compared with -20.84% in 2024.

How has Celon Pharma S.A.'s operating margin changed since 2020?

From 2020 to 2025, Celon Pharma S.A.'s operating margin was highest in 2020 (-2.33%) and lowest in 2022 (-43.08%).

How does Celon Pharma S.A.'s operating margin compare with similar companies?

Celon Pharma S.A.'s operating margin (-11.78%) is lower than that of all 5 similar companies listed above. The highest among them is MERCK Kommanditgesellschaft auf Aktien, with 19.69%.